fl-Migrating very-low-density lipoprotein (fl-VLDL) is a cholesteryl-ester-enriched lipoprotein which under normal conditions is rapidly cleared by parenchymal liver cells. In this study the characteristics of the interaction of,6-VLDL with rat parenchymal cells, Hep G2 cells and human parenchymal cells are evaluated. The binding of fl-VLDL to these cells follows saturation kinetics (Bmax respectively 117, 106 and 103 ng of 8-VLDL apoliprotein/mg of cell protein), with a relatively high affinity (Kd respectively for 8-VLDL of 10.7, 5.1 and 8.4,ag/ml). Competition studies of unlabelled /3-VLDL, low-density lipoprotein (LDL) or acetylated LDL with the binding of radiolabelled ,-VLDL indicate that a LDLreceptor-independent, Ca2+-independent, specific recognition site for ,-VLDL is present on rat and human parenchymal cells, whereas with Hep G2 cells or mouse macrophages /J-VLDL recognition is performed by the LDL receptor. The binding of /-VLDL to Hep G2 cells was down-regulated by 89 % by prolonged exposure to ,-VLDL, whereas for human parenchymal and rat parenchymal cells down-regulation of 44 % and 20 % respectively was observed. Studies with antibodies against the LDL receptor support the presence of a LDL-receptor-independent specific fl-VLDL recognition site on rat and human parenchymal cells. It is concluded that a LDL-receptor-independent recognition site for ,6-VLDL is present on rat and human parenchymal liver cells. The presence of a LDL-receptor-independent recognition site on human parenchymal cells may mediate in vivo the uptake of fl-VLDL during consumption of a cholesterol-rich diet, when LDL receptors are down-regulated, thus protecting against the extrahepatic accumulation of the atherogenic 8-VLDL constituents.
INTRODUCTION
/3-VLDL is an abnormal very-low-density lipoprotein (VLDL) that accumulates in the plasma from cholesterol-fed animals and from patients with type III hypercholesterolaemia [1] [2] [3] [4] . It is enriched in cholesteryl esters and on electrophoresis it shows /3-mobility. In blood monocytes and macrophages ,/-VLDL stimulates the synthesis and accumulation of cholesteryl esters, and this lipoprotein is thus considered to be specifically atherogenic [5] [6] [7] [8] .
The interaction of ,-VLDL with macrophages has been described in a number of studies, and it has been shown that the uptake of this lipoprotein is mediated via a high-affinity receptor, which is related to the LDL (apo B,E) receptor [8] [9] [10] . This receptor requires Ca2+ for optimal binding of ,-VLDL, whereas the cell association of radiolabelled ,-VLDL can be competed for by both unlabelled ,-VLDL and LDL. The observation that /1-VLDL binding correlates directly with the amount of LDL receptors has led to the conclusion that in macrophages a socalled unusual LDL receptor is the predominant, if not the only, receptor responsible for fl-VLDL binding. This receptor differs from the classical LDL receptor described in human fibroblasts in its low affinity for LDL and its relative resistance to downregulation by extracellular cholesterol [8] [9] [10] .
In vivo, it has been demonstrated that ,-VLDL is rapidly cleared from the blood by the liver and that predominantly the liver parenchymal cells are responsible for this uptake [11, 12] .
Experiments in vivo have shown that in dogs the clearance of ,-VLDL is retarded after cholesterol feeding or infusion with bile acids, and it was suggested that in dogs the LDL receptor is responsible for ,-VLDL uptake by liver [11] . In rats, parenchymal liver cells hardly express active LDL receptors [13, 14] , and we suggested previously that ,I-VLDL in rats is therefore recognized by a so-called remnant receptor [12] .
The existence of a remnant receptor in liver was supported by observations in patients with homozygous familial hypercholesterolaemia and WHHL rabbits in whom LDL receptors are genetically defective [15] . Both chylomicron remnants and large VLDL particles are rapidly cleared from the blood in these LDL-receptor-defective species [16, 17] , suggesting that a second receptor may mediate such clearance. Work by Herz et al. [18] suggested that a high-molecular-mass protein (the so-called LDLreceptor-related protein, LRP) might be an attractive candidate. Subsequently Kowal et al. [19, 20] , Lund et al. [21] and Beisiegel et al. [22] provided evidence that apo E might bind to LRP, although enrichment of,8-VLDL in vitro with apo E was necessary to express binding.
The aim of the present study was to characterize the ability of ,8-VLDL to interact with isolated parenchymal cells, which form in vivo the site of rapid uptake [12, 23] . [12] . /I-VLDL was labelled with 1251 at pH 10.0 by a modification [26] of the ICI method [27] . Free 1251 was removed by Sephadex G-50 gel-filtration, followed by dialysis against PBS-EDTA. The distribution of radioactivity in the labelled /-VLDL preparation was 77.6 + 10.7 % in protein, 18 .4 + 7.4 % in lipid and 3.9 + 1.4 % , / unbound, determined as described by Folch et al. [28] . The distribution of the protein-associated radioactivity over the various apoproteins was determined by electrophoresis of 5 LDL was obtained from sera from healthy fasted volunteers. These sera were centrifuged at 250000 g in a discontinuous KBr gradient for 22 h at 4°C (see above). The 1.024 < d < 1.055 fraction was re-centrifuged by the same procedure. LDL was subsequently dialysed overnight against PBS-EDTA. The apo E content of LDL was less than 0.03 % [29] . LDL was acetylated as described by Basu et al. [30] . In this procedure 1 ml of LDL, with a protein concentration between 2 and 10 mg/ml, was added to 1 ml of a saturated solution of sodium acetate (pH 7.4). This solution was placed in an ice/water bath. Under continuous stirring, acetic anhydride was added in 2 1l portions over a period of I h and in a total amount of 1.5 times the amount of protein used. The solution was then incubated for an additional 30 min and dialysed against PBS-EDTA at 4°C .
Rat parenchymal cells
Rat parenchymal cells were isolated as described previously [29, 31] . In short, a liver perfusion was performed during 10 min at 37°C, with carbogen-saturated Hanks' buffer (pH 7.4), containing glucose (1.0 g/l) and Hepes (1.6 g/l; Merck, Darmstadt, Germany) at a flow rate of 14 ml/min. The [31a] .
After resection, the left liver lobe was transported to the perfusion site within 45 min in a cold buffer (4°C) containing 10 mM-Hepes, pH 7.4, 142 mM-NaCl, 6 .7 mM-KCl and 0.5 mm-EGTA. Perfusion with 3 litres of this buffer at a rate of40 ml/min per catheter was started after insertion of four polyethylene catheters (18 gauge) in the vascular orifices that were identified at the dissection surface. After the pre-perfusion the liver was perfused successively with 500 ml of a 10 mM-Hepes buffer, pH 7.6, containing 5 mM-CaCl2 without recirculation, and with 200 ml of this buffer containing 0.05 % and 0.1 % collagenase, respectively, with recirculation for 20 10 % heat-inactivated fetal-calf serum, 2 mM-L-glutamine, 20 munits of insulin/ml, 1 nM-dexamethasone, 50 ,tg of kanamycin/ ml, 100 units of penicillin/ml and 100 ,tg of streptomycin/ml at 37°C in an atmosphere of air/CO2 (19:1) [32] .
The medium was renewed 12 h after seeding to remove unattached non-viable cells and at every 24 h thereafter. Experiments were performed with cells that had been cultured for h. The viability of the cells used in the experiments was greater than 95 %.
The hepatocytes used in this study were non-dividing cells, able to accumulate taurocholic acid intracellularly to the same extent as cultured rat hepatocytes [33] . Furthermore the cells could synthesize and secrete VLDL, LDL, HDL (with VLDL as the major species, namely 68 + 9 %), apo B, apo Al, apo All, apo E, apo CII [34] , albumin and plasminogen activator inhibitor 1 [35] . Also, the transport and metabolism of thyroid hormones were qualitatively comparable with these processes in rat hepatocytes [36] . The human hepatocytes possess a specific high-affinity site for human HDL with recognition properties similar to those described on rat hepatocytes [37] . 
Hep G2 cells
Hep G2 cells were cultured in 25 cm2 flasks, containing 5 (Fig. 1) [9] and Ellsworth et al. [10] reported that the macrophage receptor which recognizes /8-VLDL possesses an unusually low affinity for LDL, we performed competition experiments at I ,ug of 125I-fi-VLDL/ml with unlabelled competitor concentrations up to 500 4ug/ml (Figs. 2a-2d) . In addition to the various liver cells (Figs. 2b-2d) , we also analysed under the same conditions the specificity of the binding of /?-VLDL to mouse macrophages (Fig. 2a) .
In agreement with the data of Koo et al. [9] and Ellsworth et al. [10] , we found that the binding of 1251-/-VLDL to mouse macrophages can be completely competed for by unlabelled ,-VLDL and LDL, whereas acetyl-LDL is hardly effective (Fig.  2a) . With rat parenchymal cells, however, a completely different picture is obtained (Fig. 2b) Dependency of`2 5I-j6-VLDL binding on Ca2"
The binding of ligands to the LDL receptor is strictly Ca2+-dependent [40] , and the LDL-receptor-related protein also needs Ca2+ for binding of apo E-enriched 8-VLDL [20] . In contrast, Jaeckle et al. [41] identified on highly purified endosomal membranes from rat liver a specific binding site for l8-VLDL which is Ca2+-independent. Comparison of the role of Ca2+ in the binding of 125I-,/-VLDL to rat parenchymal, Hep G2 and human parenchymal cells indicates that the binding of /8-VLDL to Hep G2 cells is strictly Ca2+-dependent (Fig. 3b) . For human parenchymal cells in the absence of Ca2+ a significant binding (40 %) is still noticed (Fig.   3c ). The binding of/-VLDL to rat parenchymal cells is essentially uninfluenced by modulating the extracellular Ca2+ concentration (Fig. 3a) . Also, with rat parenchymal cells in culture the binding of ,B-VLDL was not influenced by Ca2`(results not shown).
Regulatory characteristics of f8-VLDL-binding site
A characteristic feature of the LDL receptor is its regulatory response to the cellular status of cholesterol [42] . In order to test
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The binding of /-VLDL to cultured parenchymal rat liver cells was only down-regulated by 20 %, whereas for LDL binding the percentage was 30 % (Fig. 4a) . With Hep G2 cells, however, ,-VLDL appears to be very effective as a feedback-regulator of the binding of both ,-VLDL and LDL (by 74 and 83 respectively; (Fig. 4c) .
Influence of anti-LDL-receptor antibodies on f-VLDL binding can be isolated from cholesterol-fed animals [11, 12] or from patients with type III hypercholesterolaemia [1] [2] [3] [4] . In accordance with Ellsworth et al. [10] , we observed, as described previously [12, 23] , that ,-VLDL from cholesterol-fed rats forms a homogeneous single band with f-mobility. The atherogenicity of ,3-VLDL is related to the ability to cause deposition of cholesteryl esters in macrophages, both in vivo and in vitro [5] [6] [7] [8] . However, upon injection of /J-VLDL into rats, the particles are rapidly cleared from the blood (t! 2 min) by the liver [11, 12, 23] . Recently we showed, in accordance with autoradiographic data [43] , that the rapid liver uptake is carried out by parenchymal cells [12, 23] . Already 2min after injection of [3H]cholesteryl-ester-labelled ,/-VLDL an association with small vesicles is observed, and after 10 min the highest specific activity is already localized in the lysosomal fraction [23] . The kinetics of serum decay, parenchymal-cell association and uptake in vivo are very comparable with those of ligands for specific parenchymal-cell receptors, i.e. asialofetuin for the asialoglycoprotein receptor [44] . In the present paper we characterized the interaction site for ,l-VLDL on rat parenchymal cells, and the relevance of animal studies to the human situation was verified by a direct comparison with Hep G2 cells, a cell line which is supposed to reflect [9, 10] . The data presented are in perfect accordance with the data published previously by Koo et al. [9] and Ellsworth et al. [10] [9, 10] . This conclusion is in accordance with the difficulty of showing the presence of a LDLspecific recognition site in liver from untreated rats [29, 40] . In rats the recognition of ,-VLDL is thus performed by a specific /3-VLDL receptor, which might be identical with the chylomicronremnants recognition site and thus be called remnant receptor.
Jaeckle and co-workers [41] [18] . A comparison of the binding characteristics of rat parenchymal cells and the LRP for fl-VLDL points to some distinctive differences, however. As recently published by Lund et al. [21] and Kowal et al. [20] , it appears that native ,l-VLDL binds poorly to LRP in ligand blots. An additional enrichment by added apo E appears to be needed for optimal interaction [20] . The kinetics of association of ,8-VLDL to parenchymal cells in vivo [12, 23] and the properties of cell binding in vitro (performed at 0°C ) do not indicate that additional apo E is needed for an optimal interaction of ,-VLDL with parenchymal cells. For LRP it was reported that Ca2+ is obligatory for binding of apo E-enriched /J-VLDL [20] . Our data indicate that the LDL-receptor-independent ,l-VLDL-interaction site on parenchymal cells is independent of added Ca2 . This evidence might be used to indicate that a protein other than LRP is mediating the binding of ,J-VLDL. Upon injection of ,-VLDL into rats in vivo, the particles become nearly exclusively associated with rat parenchymal liver cells. Since LRP is widely distributed among cells in the body [18] , its cellular distribution does not reflect the specificity of ,-VLDL association with rat parenchymal cells [12, 23] .
In the present work, an attempt was undertaken to verify the relevance of the findings with rats to the human situation. Hep G2 cells have been widely used as a model for human hepatocytes [45, 46] , and therefore we also performed simultaneously experiments with this cell line. It hepatocytes suggest that direct studies with human liver cells are needed to allow conclusions on the interaction of lipoproteins with the liver in the human situation. The LDL-receptorindependent recognition site for ,3-VLDL thus identified on human parenchymal cells may mediate in vivo the uptake of cholesteryl-ester-rich VLDL during a cholesterol-rich diet, when LDL receptors are down-regulated, or in LDL-receptor-deficient patients [52] , thus protecting against the extrahepatic accumulation of the atherogenic fl-VLDL constituents.
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